Wen-Wei Lin
- Molecular Biology
- Oncology
- Radiology, Nuclear Medicine and Imaging top 10%
- Biomedical Engineering
- Biomaterials top 10%
- Co-authors
- Tian‐Lu ChengYun‐Chi LuChih-Hung ChuangYuan-Chin HsiehI‐Ju ChenSteve R. RofflerYi‐An ChengKai-Wen Cheng
- Topics
- Monoclonal and Polyclonal Antibodies Research (14 papers)Esophageal Cancer Research and Treatment (9 papers)Glycosylation and Glycoproteins Research (7 papers)
- Journals
- ACS NanoPLoS ONEAnalytical Chemistry
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wen-Wei Lin
50 papers receiving 680 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 307
- Oncology 147
- Radiology, Nuclear Medicine and Imaging 122
- Biomedical Engineering 115
- Biomaterials 107
Countries citing papers authored by Wen-Wei Lin
This map shows the geographic impact of Wen-Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Wei Lin more than expected).
Fields of papers citing papers by Wen-Wei Lin
This network shows the impact of papers produced by Wen-Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Wei Lin. The network helps show where Wen-Wei Lin may publish in the future.
Co-authorship network of co-authors of Wen-Wei Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Wei Lin. A scholar is included among the top collaborators of Wen-Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Wei Lin. Wen-Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 50 | |
| 10 | 14 | |
| 11 | 5 | |
| 12 | 30 | |
| 13 | 34 | |
| 14 | 8 | |
| 15 | 1 | |
| 16 | 14 | |
| 17 | 20 | |
| 18 | 10 | |
| 19 | 8 | |
| 20 | 26 |
About Wen-Wei Lin
Wen-Wei Lin is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomaterials and Applied Microbiology and Biotechnology, having authored 56 papers that have together received 689 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Esophageal Cancer Research and Treatment (9 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Biomaterials (107 citations), Oncology (147 citations) and Radiology, Nuclear Medicine and Imaging (122 citations). Wen-Wei Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Tian‐Lu Cheng, Yun‐Chi Lu, Chih-Hung Chuang, Yuan-Chin Hsieh, I‐Ju Chen, Steve R. Roffler, Yi‐An Cheng, Kai-Wen Cheng, Mingqiang Kang and Yeng‐Tseng Wang. Their work appears in journals such as ACS Nano, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.